| Dr Patrick A Egbe, MD | |
|
3333 Jodeco Road, Suite A, Mcdonough, GA 30253 | |
| (770) 692-4000 | |
| (770) 474-8510 |
| Full Name | Dr Patrick A Egbe |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 44 Years |
| Location | 3333 Jodeco Road, Mcdonough, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699762419 | NPI | - | NPPES |
| 000439425D | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 033571 (Georgia) | Primary |
| 207R00000X | Internal Medicine | 033571 (Georgia) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southern Regional Medical Center | Riverdale, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Atlanta Heart Associates | 6204737216 | 21 |
News Archive
A comprehensive appraisal of the management and treatment options for low-risk prostate cancer found that the rates of survival and tumor recurrence are similar among the most common treatment approaches, although costs can vary considerably.
Northeast Wisconsin's nationally recognized Affinity Health System is the latest to choose GE Centricity® EMR for its patient care network. The Catholic, mission-oriented, regional health network is a collaboration between the Fox Valley's Ministry Health Care and Wheaton Franciscan Healthcare and plans to implement Centricity EMR across its 22 multi-specialty clinics in 14 communities to help care for an average of 21,000 patients each year.
Intellect Neurosciences, Inc., a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and multiple licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has obtained a draft pharmacokinetic report from its completed Phase 1b trial for its lead Alzheimer's candidate, OX1. The Company previously reported on the safety aspects of the trial, which demonstrated that OX1 is safe and well tolerated at all dose levels tested.
UCLA researchers have discovered that a combination of high doses of radiotherapy and hormonal therapy provides the best chance of decreasing the mortality rate in men with aggressive prostate cancer.
Premier Research Group Limited, an international CRO with considerable oncology research expertise, is pleased to announce that Dr. Liddy Chen has received a Doctorate degree in Biostatistics, focusing on study design issues in advanced survival models with major application to oncology clinical trials, from University of North Carolina at Chapel Hill.
› Verified 4 days ago
| Entity Name | Atlanta Heart Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851327241 PECOS PAC ID: 6204737216 Enrollment ID: O20040114000144 |
News Archive
A comprehensive appraisal of the management and treatment options for low-risk prostate cancer found that the rates of survival and tumor recurrence are similar among the most common treatment approaches, although costs can vary considerably.
Northeast Wisconsin's nationally recognized Affinity Health System is the latest to choose GE Centricity® EMR for its patient care network. The Catholic, mission-oriented, regional health network is a collaboration between the Fox Valley's Ministry Health Care and Wheaton Franciscan Healthcare and plans to implement Centricity EMR across its 22 multi-specialty clinics in 14 communities to help care for an average of 21,000 patients each year.
Intellect Neurosciences, Inc., a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and multiple licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has obtained a draft pharmacokinetic report from its completed Phase 1b trial for its lead Alzheimer's candidate, OX1. The Company previously reported on the safety aspects of the trial, which demonstrated that OX1 is safe and well tolerated at all dose levels tested.
UCLA researchers have discovered that a combination of high doses of radiotherapy and hormonal therapy provides the best chance of decreasing the mortality rate in men with aggressive prostate cancer.
Premier Research Group Limited, an international CRO with considerable oncology research expertise, is pleased to announce that Dr. Liddy Chen has received a Doctorate degree in Biostatistics, focusing on study design issues in advanced survival models with major application to oncology clinical trials, from University of North Carolina at Chapel Hill.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Patrick A Egbe, MD 3333 Jodeco Road, Suite A, Mcdonough, GA 30253 Ph: (770) 692-4000 | Dr Patrick A Egbe, MD 3333 Jodeco Road, Suite A, Mcdonough, GA 30253 Ph: (770) 692-4000 |
News Archive
A comprehensive appraisal of the management and treatment options for low-risk prostate cancer found that the rates of survival and tumor recurrence are similar among the most common treatment approaches, although costs can vary considerably.
Northeast Wisconsin's nationally recognized Affinity Health System is the latest to choose GE Centricity® EMR for its patient care network. The Catholic, mission-oriented, regional health network is a collaboration between the Fox Valley's Ministry Health Care and Wheaton Franciscan Healthcare and plans to implement Centricity EMR across its 22 multi-specialty clinics in 14 communities to help care for an average of 21,000 patients each year.
Intellect Neurosciences, Inc., a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and multiple licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has obtained a draft pharmacokinetic report from its completed Phase 1b trial for its lead Alzheimer's candidate, OX1. The Company previously reported on the safety aspects of the trial, which demonstrated that OX1 is safe and well tolerated at all dose levels tested.
UCLA researchers have discovered that a combination of high doses of radiotherapy and hormonal therapy provides the best chance of decreasing the mortality rate in men with aggressive prostate cancer.
Premier Research Group Limited, an international CRO with considerable oncology research expertise, is pleased to announce that Dr. Liddy Chen has received a Doctorate degree in Biostatistics, focusing on study design issues in advanced survival models with major application to oncology clinical trials, from University of North Carolina at Chapel Hill.
› Verified 4 days ago
Christian Aidoo, M.D Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2303 Flowers Creek Dr, Mcdonough, GA 30253 Phone: 770-686-6511 | |
John Darrell Smith, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3333 Jodeco Road, Suite A, Mcdonough, GA 30253 Phone: 770-692-4000 Fax: 770-474-8510 | |
Gopal C Rao, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3333 Jodeco Road, Suite A, Mcdonough, GA 30253 Phone: 770-692-4000 Fax: 770-474-8510 | |
Willie F Rainey, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1125 Town Center Village Dr, Henry Towne Centre Medical Center, Mcdonough, GA 30253 Phone: 678-583-6600 | |
Dr. Gregory Paul Petro, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3333 Jodeco Road, Suite A, Mcdonough, GA 30253 Phone: 770-692-4000 Fax: 770-474-8510 | |
Meryl L Braunstein, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3333 Jodeco Road, Suite A, Mcdonough, GA 30253 Phone: 770-692-4000 Fax: 770-474-8510 | |
Dagmawit Assefa Mekuria, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 50 Kelly Rd, Mcdonough, GA 30253 Phone: 770-914-0116 |